This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Kerlone (Betaxolol) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (16)
Disability (2)
Reports by Reaction Type
Renal Failure Acute (5),
Intestinal Obstruction (5),
Renal Failure (5),
Dehydration (5),
Drug Eruption (4),
Adverse Drug Reaction (4),
Fear (4),
Overdose (4),
Fatigue (4),
Upper Respiratory Tract Infection (4),
Abnormal Loss of Weight (4),
Pancreatic Enzymes Increased (4)
Possible Kerlone side effects in 60 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-03
Patient: 60 year old male
Reactions: Hypotension, Shock, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kerlone
Administration route: Oral
Start date: 2012-06-13
End date: 2012-06-29
Isoptin
Administration route: Oral
Start date: 2012-06-13
End date: 2012-06-29
Possible Kerlone side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-13
Patient: 50 year old male
Reactions: Renal Failure, Amylase Increased, Dehydration, Condition Aggravated, Lipase Increased, Intestinal Obstruction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rilmenidine (Rilmenidine)
Dosage: (1 mg qd oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Kerlone
Dosage: (20 mg qd oral) ; (df)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Kerlone
Dosage: (20 mg qd oral) ; (df)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-20
Atorvastatin Calcium
Dosage: (20 mg qd oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Allopurinol
Dosage: (300 mg qd oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Lercanidipine
Dosage: (20 mg qd oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Novonorm (Novo-Norm-Ripaglinide) (Not Specified)
Dosage: (3 mg tid oral) ; (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Novonorm (Novo-Norm-Ripaglinide) (Not Specified)
Dosage: (3 mg tid oral) ; (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-19
Sitagliptin Phosphate
Dosage: (50 mg qd oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Enalapril Maleate and Hydrochlorothiazide
Dosage: (once daily oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Oxycodone HCL
Dosage: (10 mg, frequency unknown oral)
Administration route: Oral
Indication: Back Pain
Start date: 2011-07-13
End date: 2011-08-09
Other drugs received by patient: Tacrolimus; Cellcept; Prednisone TAB
Possible Kerlone side effects in 33 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-06
Patient: 33 year old female, weighing 51.8 kg (114.0 pounds)
Reactions: Drug Eruption, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Omeprazole
Indication: Gastritis Prophylaxis
End date: 2011-04-18
Amlodipine Besylate
Indication: Hypertension
End date: 2011-04-18
Rasilez (Aliskiren) (Aliskiren)
Indication: Hypertension
End date: 2011-04-18
Olmesartan Medoxomil
Indication: Hypertension
End date: 2011-04-18
Trichlormethiazide
Indication: Hypertension
End date: 2011-04-18
Lasix
Indication: Hypertension
End date: 2011-04-18
Kerlone
Indication: Hypertension
End date: 2011-04-18
Possible Kerlone side effects in 33 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-06
Patient: 33 year old female
Reactions: Drug Eruption, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kerlone
Dosage: unk
Indication: Hypertension
End date: 2011-04-18
Trichlormethiazide
Dosage: unk
Indication: Hypertension
End date: 2011-04-18
Olmesartan Medoxomil
Dosage: unk
Indication: Hypertension
End date: 2011-04-18
Rasilez
Dosage: unk
Indication: Hypertension
End date: 2011-04-18
Famotidine
Dosage: unk
Indication: Gastritis Prophylaxis
End date: 2011-04-18
Lasix
Dosage: unk
Indication: Hypertension
End date: 2011-04-18
Amlodipine
Dosage: unk
Indication: Hypertension
End date: 2011-04-18
Possible Kerlone side effects in 33 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-23
Patient: 33 year old female
Reactions: Drug Eruption, Malaise, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Olmesartan Medoxomil
Dosage: unk
Administration route: Oral
Indication: Hypertension
End date: 2011-04-18
Lasix
Dosage: unk
Indication: Hypertension
End date: 2011-04-18
Rasilez
Dosage: unk
Indication: Hypertension
End date: 2011-04-18
Amlodipine
Dosage: unk
Administration route: Oral
Indication: Hypertension
End date: 2011-04-18
Kerlone
Dosage: unk
Indication: Hypertension
End date: 2011-04-18
Famotidine
Dosage: unk
Indication: Gastritis Prophylaxis
End date: 2011-04-18
Trichlormethiazide
Dosage: unk
Indication: Hypertension
End date: 2011-04-18
Possible Kerlone side effects in 33 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-19
Patient: 33 year old female, weighing 51.8 kg (114.0 pounds)
Reactions: Drug Eruption, Fibromuscular Dysplasia, Malaise, Erythema, Renal Failure Acute, Renal Artery Stenosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kerlone
Indication: Hypertension
End date: 2011-04-18
Olmesartan Medoxomil
Indication: Hypertension
End date: 2011-04-18
Lasix
Indication: Hypertension
End date: 2011-04-18
Amlodipine Besylate
Indication: Hypertension
End date: 2011-04-18
Rasilez (Aliskiren) (Aliskiren)
Indication: Hypertension
End date: 2011-04-18
Trichlormethiazide
Indication: Hypertension
End date: 2011-04-18
Omeprazole
Indication: Gastritis Prophylaxis
End date: 2011-04-18
Possible Kerlone side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-27
Patient: female, weighing 81.7 kg (179.6 pounds)
Reactions: Wrong Technique in Drug Usage Process, Osteoporosis, Fear, Adverse Drug Reaction, Overdose, Fatigue, Medication Error, Upper Respiratory Tract Infection, Abnormal Loss of Weight, Depression, Kidney Infection, Nervousness, Decreased Appetite, Product Quality Issue, Psychomotor Hyperactivity, Abnormal Behaviour, Tremor, Convulsion, Anxiety, Arthralgia, Heart Rate Increased, Insomnia, Disturbance in Attention, DRY Eye, Asthenia, Feeling Abnormal, Accidental Exposure
Drug(s) suspected as cause:
Topiramate
Administration route: Oral
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topamax
Administration route: Oral
Start date: 2011-08-22
Topamax
Administration route: Oral
Start date: 2011-08-22
Topamax
Administration route: Oral
Start date: 2011-07-01
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Indication: Convulsion
Start date: 2008-01-01
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Indication: Migraine
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Celexa
Indication: Product Used FOR Unknown Indication
Trazodone Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Migraine Prophylaxis
Topiramate
Administration route: Oral
Unknown Medication
Indication: Product Used FOR Unknown Indication
Topiramate
Administration route: Oral
Indication: Migraine
Topamax
Administration route: Oral
Start date: 2001-01-26
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2008-01-01
Kerlone
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-26
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topamax
Administration route: Oral
Indication: Convulsion
Topiramate
Administration route: Oral
Indication: Epilepsy
Start date: 2008-01-01
Topiramate
Administration route: Oral
Topiramate
Administration route: Oral
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topamax
Administration route: Oral
Start date: 2001-01-26
Possible Kerlone side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-21
Patient:
Reactions: Renal Failure, Dehydration, Intestinal Obstruction, Pancreatic Enzymes Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2011-08-09
Lercanidipine
Dosage: 20 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Kerlone
Dosage: 20 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Repaglinide
Dosage: unk
Administration route: Oral
Start date: 2011-08-19
Rilmenidine
Dosage: 1 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Allopurinol
Dosage: 300 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Januvia
Dosage: 0.5 pharmaceutical dose daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Kerlone
Dosage: unk
Start date: 2011-08-20
Atorvastatin Calcium
Dosage: 20 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Oxycontin
Dosage: 10 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-13
End date: 2011-08-09
Other drugs received by patient: Tacrolimus; Cellcept; Prednisone
Possible Kerlone side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-19
Patient: female, weighing 81.7 kg (179.6 pounds)
Reactions: Wrong Technique in Drug Usage Process, Adverse Drug Reaction, Fear, Fatigue, Overdose, Upper Respiratory Tract Infection, Medication Error, Abnormal Loss of Weight, Nervousness, Decreased Appetite, Product Quality Issue, Psychomotor Hyperactivity, Convulsion, Tremor, Anxiety, Arthralgia, Heart Rate Increased, Insomnia, Disturbance in Attention, Asthenia, Feeling Abnormal, Accidental Exposure
Drug(s) suspected as cause:
Topiramate
Administration route: Oral
Indication: Migraine Prophylaxis
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2008-01-01
Unknown Medication
Indication: Product Used FOR Unknown Indication
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topamax
Administration route: Oral
Indication: Convulsion
Start date: 2001-01-26
Topamax
Administration route: Oral
Start date: 2011-08-22
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Celexa
Indication: Product Used FOR Unknown Indication
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Topiramate
Administration route: Oral
Indication: Epilepsy
Start date: 2008-01-01
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Trazodone Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Convulsion
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2011-01-01
End date: 2011-06-27
Topamax
Administration route: Oral
Start date: 2001-01-26
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topamax
Administration route: Oral
Indication: Migraine
Start date: 2011-08-22
Topamax
Administration route: Oral
Start date: 2011-07-01
Kerlone
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-26
Possible Kerlone side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-19
Patient: 50 year old male
Reactions: Renal Failure, Dehydration, Pancreatic Enzymes Increased, Intestinal Obstruction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atorvastatin Calcium
Administration route: Oral
End date: 2011-08-09
Enalapril Maleate and Hydrochlorothiazide
Administration route: Oral
End date: 2011-08-09
Januvia
Administration route: Oral
End date: 2011-08-09
Rilmenidine
Administration route: Oral
End date: 2011-08-09
Kerlone
Administration route: Oral
End date: 2011-08-09
Lercanidipine
Administration route: Oral
End date: 2011-08-09
Repaglinide
Administration route: Oral
End date: 2011-08-09
Allopurinol
Administration route: Oral
End date: 2011-08-09
Oxycontin
Administration route: Oral
Start date: 2011-07-13
End date: 2011-08-09
Possible Kerlone side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-13
Patient: 50 year old male
Reactions: Renal Failure, Dehydration, Pancreatic Enzymes Increased, Intestinal Obstruction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atorvastatin Calcium
Dosage: 20 mg, 1x/day
Administration route: Oral
End date: 2011-08-09
Januvia
Dosage: 0.5 df, 1x/day
Administration route: Oral
End date: 2011-08-09
Repaglinide
Dosage: 3 mg, 3x/day
Administration route: Oral
End date: 2011-08-09
Oxycontin
Dosage: 10 mg, unk
Administration route: Oral
Indication: Back Pain
Start date: 2011-07-13
End date: 2011-08-09
Rilmenidine
Dosage: 1 mg, 1x/day
Administration route: Oral
End date: 2011-08-09
Allopurinol
Dosage: 300 mg, 1x/day
Administration route: Oral
End date: 2011-08-09
Lercanidipine
Dosage: 20 mg, 1x/day
Administration route: Oral
End date: 2011-08-09
Kerlone
Dosage: 20 mg, 1x/day
Administration route: Oral
End date: 2011-08-09
Enalapril Maleate and Hydrochlorothiazide
Dosage: 1 df, 1x/day
Administration route: Oral
End date: 2011-08-09
Other drugs received by patient: Mycophenolate Mofetil (Cellcept); Tacrolimus; Prednisone
Possible Kerlone side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-12
Patient: male
Reactions: Renal Failure, Dehydration, Intestinal Obstruction, Pancreatic Enzymes Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lercanidipine
Dosage: 20 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Atorvastatin Calcium
Dosage: 20 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Enalapril Maleate and Hydrochlorothiazide
Dosage: 1 df, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Allopurinol
Dosage: 300 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Repaglinide
Dosage: 3 mg, tid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Januvia
Dosage: 0.5 df, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Rilmenidine
Dosage: 1 df, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Oxycodone HCL
Dosage: unk
Administration route: Oral
Indication: Pain
Start date: 2011-07-13
End date: 2011-08-09
Kerlone
Dosage: 20 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2011-08-09
Possible Kerlone side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-11
Patient: female, weighing 81.7 kg (179.6 pounds)
Reactions: Wrong Technique in Drug Usage Process, Adverse Drug Reaction, Fear, Overdose, Fatigue, Medication Error, Upper Respiratory Tract Infection, Abnormal Loss of Weight, Decreased Appetite, Nervousness, Product Quality Issue, Psychomotor Hyperactivity, Convulsion, Tremor, Anxiety, Arthralgia, Insomnia, Heart Rate Increased, Disturbance in Attention, Asthenia, Feeling Abnormal, Accidental Exposure
Drug(s) suspected as cause:
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Kerlone
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-26
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topamax
Administration route: Oral
Start date: 2011-08-22
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Start date: 2001-01-26
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2008-01-01
Unknown Medication
Indication: Product Used FOR Unknown Indication
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topamax
Administration route: Oral
Indication: Migraine
Start date: 2011-08-22
Topamax
Administration route: Oral
Start date: 2011-07-01
Celexa
Indication: Product Used FOR Unknown Indication
Trazodone Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Migraine Prophylaxis
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topiramate
Administration route: Oral
Indication: Convulsion
Start date: 2005-01-01
End date: 2011-01-01
Topamax
Administration route: Oral
Indication: Convulsion
Start date: 2001-01-26
Topiramate
Administration route: Oral
Indication: Epilepsy
Start date: 2008-01-01
Possible Kerlone side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-10
Patient: female, weighing 81.7 kg (179.6 pounds)
Reactions: Wrong Technique in Drug Usage Process, Fear, Adverse Drug Reaction, Fatigue, Overdose, Upper Respiratory Tract Infection, Medication Error, Abnormal Loss of Weight, Nervousness, Decreased Appetite, Product Quality Issue, Psychomotor Hyperactivity, Convulsion, Tremor, Anxiety, Arthralgia, Heart Rate Increased, Insomnia, Disturbance in Attention, Asthenia, Feeling Abnormal, Accidental Exposure
Drug(s) suspected as cause:
Topamax
Administration route: Oral
Indication: Convulsion
Start date: 2001-01-26
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2011-01-01
End date: 2011-06-27
Topamax
Administration route: Oral
Indication: Migraine
Start date: 2011-08-22
Celexa
Indication: Product Used FOR Unknown Indication
Trazodone Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-01
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Migraine Prophylaxis
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2011-01-01
End date: 2011-06-27
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Start date: 2011-07-01
Topiramate
Administration route: Oral
Indication: Epilepsy
Start date: 2008-01-01
Unknown Medication
Indication: Product Used FOR Unknown Indication
Topamax
Administration route: Oral
Start date: 2001-01-26
Topiramate
Administration route: Oral
Indication: Migraine
Start date: 2008-01-01
Topiramate
Administration route: Oral
Indication: Convulsion
Start date: 2005-01-01
End date: 2011-01-01
Topiramate
Administration route: Oral
Start date: 2008-01-01
Topamax
Administration route: Oral
Start date: 2011-08-22
Topamax
Administration route: Oral
Start date: 2011-06-27
End date: 2011-07-01
Topamax
Administration route: Oral
Start date: 2011-07-01
Topamax
Administration route: Oral
Kerlone
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-26
Topiramate
Administration route: Oral
Start date: 2005-01-01
End date: 2011-01-01
Possible Kerlone side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-07
Patient: 68 year old female
Reactions: Pain, Muscular Weakness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Kerlone
Administration route: Oral
Start date: 2000-01-01
End date: 2011-03-01
Crestor
Administration route: Oral
Start date: 2006-09-01
End date: 2009-09-01
Kerlone
Administration route: Oral
Indication: Migraine
Start date: 2000-01-01
End date: 2011-03-01
Possible Kerlone side effects in 68 year old female
Reported by a physician from France on 2011-10-05
Patient: 68 year old female
Reactions: Pain, Muscular Weakness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Kerlone
Administration route: Oral
Indication: Hypertension
Start date: 2000-01-01
End date: 2011-03-01
Crestor
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2006-09-01
End date: 2009-09-01
Kerlone
Administration route: Oral
Indication: Migraine
Start date: 2000-01-01
End date: 2011-03-01
|
